Delayed pancreatic metastasis from renal cell carcinoma managed with pazopanib and stereotactic ablative body radiotherapy

采用帕唑帕尼和立体定向消融放射治疗治疗肾细胞癌延迟性胰腺转移

阅读:1

Abstract

The pancreas is a rare site of distant metastasis from renal cell carcinoma. We present the case of a 68-year-old man with a prior history of left radical nephrectomy for renal cell carcinoma, who was found to have an isolated pancreatic metastasis in the pancreatic tail during routine follow-up imaging 4 years postsurgery. The patient was initially managed with pazopanib, but due to progressive growth of the pancreatic lesion without other metastatic sites, stereotactic ablative body radiotherapy (SABR) was given, with complete response at 12 months after SABR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。